Cycrimine

Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]

Cycrimine
Clinical data
License data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
ECHA InfoCard100.000.932
Chemical and physical data
FormulaC19H29NO
Molar mass287.447 g·mol−1
3D model (JSmol)

Synthesis

Cycrimine synthesis:[2]
gollark: No, they just simulate all possible things ever, as I mentioned.
gollark: Why would we have those?
gollark: Correction: this is actually just being simulated by one of the paperclip AIs for no particular reason.
gollark: Oh, I've been informed that the main purpose of this simulation is actually to create Macron. Weird.
gollark: According to our analysts, this is actually just one of our simulations, to simulate the effects of a GTech™ unable to create proper AI.

See also

References

  1. Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, page 218
  2. Denton, J. J.; Schedl, H. P.; Lawson, Virginia A.; Neier, W. B. (1950). "Antispasmodics. VII.1 Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.